Gellert K, Agnes A, Noack F, Benhidjeb T, Jacobi C
Klinik und Poliklinik für Chirurgie, Humboldt-Universität zu Berlin.
Zentralbl Chir. 1996;121(2):87-9.
Since 1982 a total number of 1062 patients underwent surgical treatment of bronchogenic carcinoma. There were 972 men and 89 women, with a mean age of 62.5 years. In 484 cases a squamous cell carcinoma was diagnosed and in 416 patients an adenocarcinoma. An alveolar cell carcinoma was found in 54 and a polymorphocellular carcinoma in 68 patients respectively. 334 patients were found to be in stage I, 233 in stage II and 438 patients were in stage IIIa. The 5-year survival rate was 57.2% in stage I and 32.5% in stage II. The group of patients with N2 lymph node metastasis according stage IIIa showed a very poor 5-year-survival rate of 12.3%. A standard therapeutical procedure according to a multimodal concept is necessary to improve these patients' long-term survival. Systemic lymphadenectomy is essential for adequate therapy.
自1982年以来，共有1062例患者接受了支气管源性癌的外科治疗。其中男性972例，女性89例，平均年龄62.5岁。484例诊断为鳞状细胞癌，416例为腺癌。分别在54例患者中发现肺泡细胞癌，68例患者中发现多形细胞癌。334例患者处于I期，233例处于II期，438例患者处于IIIa期。I期患者的5年生存率为57.2%，II期为32.5%。根据IIIa期，有N2淋巴结转移的患者组5年生存率非常低，为12.3%。根据多模式概念的标准治疗程序对于提高这些患者的长期生存率是必要的。系统性淋巴结清扫术对于充分治疗至关重要。
